Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Chromogranin A ELISA Kit (AC3938)
Cat.#: ASET-2527
Specifications
Description Human Chromogranin A ELISA Kit allows for the in vitro quantitative determination of human Chromogranin A concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.469 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.781-50 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2236 Human SEMA3B ELISA Kit (AC3647) Quantitative inquiry ASET-2211 Mouse Myelin Oligodendrocyte Glycoprotein ELISA Kit (AC3622) Quantitative inquiry ASET-2323 Human BLMH ELISA Kit (AC3734) Quantitative inquiry ASET-1851 Human APC ELISA Kit (AC3262) Quantitative inquiry ASET-1435 Monkey Heme Oxygenase 1 ELISA Kit (AC2846) Quantitative inquiry ASET-1166 Human LRP5 ELISA Kit (AC2577) Quantitative inquiry ASET-1136 Human HAS1 ELISA Kit (AC2547) Quantitative inquiry ASET-2066 Porcine LIF ELISA Kit (AC3477) Quantitative inquiry ASET-1691 Human Aldolase C ELISA Kit (AC3102) Quantitative inquiry ASET-2491 Human ABCA2 ELISA Kit (AC3902) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket